23andMe Holding Co (ME) Sof foyda bo'yicha sotuv rentabelligi

23andMe Holding Co - ME emitenti grafik logotipi

Pullik obuna modeliga va AI asosidagi sog'liqni saqlash tahlillariga o'tish o'rtacha natija bermoqda, terapevtik ishlanmalar esa 23andMe Holding Co. (ME) uchun hali ham shakllanish bosqichida. Geopolitik keskinliklar patent himoyasi va komponentlar logistikasini murakkablashtirmoqda. Kompaniyaning sof marja profili ushbu xavflarni tasdiqlaydi, bunda ko'rsatkich -187.00 darajasida turibdi. Biroq, genetik testlarni ulkan DNK ma'lumotlari bazasiga asoslangan dori vositalarini kashf qilish bilan integratsiya qilish orqali diversifikatsiya qilish barqarorlik uchun noyob asos yaratadi.

23andMe Holding Co. (ME) - Sof foyda normasi 04.07.2022dan 05.04.2025gacha

23andMe Inc. (ME) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning jamlanma tahlili:23andMe Holding Co - ME
23andMe Holding Co ishlab chiqargan mahsulot

Xarajatlarni qayta tuzilishi va 23andMe Holding Co. (ME) xususiylashtirilishi sharoitida, sof foyda marjasi grafigi samaradorlikni monitoring qilish uchun asosiy vositaga aylanmoqda. Ushbu ko'rsatkich umumiy daromadga nisbatan sof foydaning ulushini belgilaydi. Hisob-kitoblar yakuniy foydaning umumiy daromadga kunlik solishtirilishiga asoslangan. Ijobiy dinamika Anne Wojcicki strategiyasining muvaffaqiyatini tasdiqlaydi; biroq, investorlar operatsion o'sishni yo'qqa chiqarishi mumkin bo'lgan qarz yuklamasini hisobga olishlari kerak.

23andMe Holding Co. (ME) raqobatchilari

A (Agilent Technologies) - Sof foyda bo'yicha sotuv rentabelligi|DGX: Kompaniyaning sof rentabelligi|Sof marja Illumina Platform|EXAS (Exact Sciences) - Kompaniyaning sof rentabelligi|Sof foyda bo'yicha sotuv rentabelligi RVTY (PerkinElmer)|Bio-Rad - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi NNNN (Anbio)|Sof foyda normasi SHC|QDEL - Sof marja|OPK: Sof marja|caredx.com (CDNA) - Sof marja|MRVI (Maravai LifeSciences) - Sof marja|FLGT (Fulgent) - Sotuvning sof marjinal rentabelligi|Standard BioTools Inc (LAB) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi CTKB|Sof foyda bo'yicha sotuv rentabelligi OraSure Technologies Inc OSUR|Sotuvning sof marjinal rentabelligi XGN (Exagen Diagnostics)|Sotuvning sof marjinal rentabelligi mdxhealth.com MDXH|LUCD - Sof marja|PRE: Sof marja|IMDX (Insight Molecular Diagnostics Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Trinity Biotech PLC|PRPH (prophaselabs.com) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Ainos, Inc. (AIMD)|Sotuvning sof marjinal rentabelligi CODX|HSCS (HeartSciences) - Sof foyda normasi|Sof marja Biomerica, Inc BMRA|CDIO - Sof foyda bo'yicha sotuv rentabelligi|ONCO - Sof marja|VRAX - Sotuvning sof marjinal rentabelligi|Bluejay Diagnostics Inc (BJDX) - Sof marja|Aspira Women's Health Inc. - Sof foyda normasi|AXDX (Accelerate Diagnostics Inc) - Sotuvning sof marjinal rentabelligi|Sof marja Centogene N.V. CNTG|Sotuvning sof marjinal rentabelligi ENZ|Sof marja FRES (Fresh2)|Sotuvning sof marjinal rentabelligi GENE (Genetic Technologies Limited)|Psychemedics Corp. (PMD) - Sof marja